Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/18/2025 | $344.00 → $395.00 | Neutral → Buy | UBS |
| 1/8/2025 | $357.00 → $373.00 | In-line → Outperform | Evercore ISI |
| 12/20/2024 | $352.00 → $382.00 | Hold → Buy | Jefferies |
| 12/5/2024 | $365.00 → $400.00 | Outperform → Strong Buy | Raymond James |
| 9/5/2024 | $278.00 | Underweight | Barclays |
| 5/22/2024 | $272.00 → $304.00 | Underperform → Neutral | BofA Securities |
| 2/12/2024 | $236.00 → $298.00 | Underperform → Market Perform | BMO Capital Markets |
| 2/12/2024 | $236.00 → $315.00 | Neutral → Buy | Citigroup |
UBS upgraded Willis Towers Watson from Neutral to Buy and set a new price target of $395.00 from $344.00 previously
Evercore ISI upgraded Willis Towers Watson from In-line to Outperform and set a new price target of $373.00 from $357.00 previously
Jefferies upgraded Willis Towers Watson from Hold to Buy and set a new price target of $382.00 from $352.00 previously